{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:44:01Z","timestamp":1790977441334,"version":"4.1.0"},"reference-count":20,"publisher":"American Association for Cancer Research (AACR)","issue":"3","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Controlled protein degradation mediated by ubiquitin\/proteasome system (UPS) plays a crucial role in modulating a broad range of cellular responses. Dysregulation of the UPS often accompanies tumorigenesis and progression. Here, we report that Smad ubiquitination regulatory factor 2 (Smurf2), a HECT-domain containing E3 ubiquitin ligase, is up-regulated in certain breast cancer tissues and cells. We show that reduction of Smurf2 expression with specific short interfering RNA in metastatic breast cancer cells induces cell rounding and reorganization of the actin cytoskeleton, which are associated with a less motile and invasive phenotype. Overexpression of Smurf2 promotes metastasis in a nude mouse model and increases migration and invasion of breast cancer cells. Moreover, expression of Smurf2CG, an E3 ligase\u2013defective mutant of Smurf2, suppresses the above metastatic behaviors. These results establish an important role for Smurf2 in breast cancer progression and indicate that Smurf2 is a novel regulator of breast cancer cell migration and invasion. [Cancer Res 2009;69(3):735\u201340]<\/jats:p>","DOI":"10.1158\/0008-5472.can-08-1463","type":"journal-article","created":{"date-parts":[[2009,1,20]],"date-time":"2009-01-20T20:45:30Z","timestamp":1232484330000},"page":"735-740","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Smad Ubiquitination Regulatory Factor 2 Promotes Metastasis of Breast Cancer Cells by Enhancing Migration and Invasiveness"],"prefix":"10.1158","volume":"69","author":[{"given":"Chaoyang","family":"Jin","sequence":"first","affiliation":[{"name":"1Laboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-an","family":"Yang","sequence":"additional","affiliation":[{"name":"1Laboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam R.","family":"Anver","sequence":"additional","affiliation":[{"name":"2Pathology\/Histotechnology Laboratory and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Morris","sequence":"additional","affiliation":[{"name":"3Animal Sciences Program, Science Applications International Corporation-Frederick, Inc., National Cancer Institute, Frederick, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangchun","family":"Wang","sequence":"additional","affiliation":[{"name":"1Laboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying E.","family":"Zhang","sequence":"additional","affiliation":[{"name":"1Laboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2009,1,29]]},"reference":[{"key":"2022061701332714800_B1","doi-asserted-by":"crossref","unstructured":"Hershko A, Ciechanover A. Annu Rev Biochem\u20081998; 67: 425\u201379.","DOI":"10.1146\/annurev.biochem.67.1.425"},{"key":"2022061701332714800_B2","doi-asserted-by":"crossref","unstructured":"Zhang YE, Yamashita M. Smurfs in TGF-\u03b2 signaling and regulation of bone homeostasis and cancer. In: Jakowlew SB, editor. Transforming growth factor-\u03b2 in cancer therapy. Humana Press; 2008. Vol 1, p. 155\u201368.","DOI":"10.1007\/978-1-59745-292-2_10"},{"key":"2022061701332714800_B3","doi-asserted-by":"crossref","unstructured":"Wang HR, Zhang Y, Ozdamar B, et al. Regulation of cell polarity and protrusion formation by targeting RhoA for degradation. Science\u20082003; 302: 1775\u20139.","DOI":"10.1126\/science.1090772"},{"key":"2022061701332714800_B4","doi-asserted-by":"crossref","unstructured":"Schwamborn JC, Muller M, Becker AHM, Puschel AW. Ubiquitination of the GTPase Rap1B by the ubiquitin ligase Smurf2 is required for the establishment of neuronal polarity. EMBO J\u20082007; 26: 1410\u201322.","DOI":"10.1038\/sj.emboj.7601580"},{"key":"2022061701332714800_B5","unstructured":"Fukuchi M, Fukai Y, Masuda N, et al. High-level expression of the Smad ubquitin ligase Smurf2 correlates with poor prognosis in patients with esophageal squamous cell carcinoma. Cancer Res\u20082002; 62: 7162\u20135."},{"key":"2022061701332714800_B6","doi-asserted-by":"crossref","unstructured":"Santner SJ, Dawson PJ, Tait L, et al. Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells. Breast Cancer Res Treat\u20082001; 65: 101\u201310.","DOI":"10.1023\/A:1006461422273"},{"key":"2022061701332714800_B7","doi-asserted-by":"crossref","unstructured":"Zhang Y, Chang C, Gehling DJ, Hemmati-Brivanlou A, Derynck R. Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase. Proc Natl Acad Sci U S A\u20082001; 98: 974\u20139.","DOI":"10.1073\/pnas.98.3.974"},{"key":"2022061701332714800_B8","doi-asserted-by":"crossref","unstructured":"Ying SX, Hussain ZJ, Zhang YE. Smurf1 facilitates myogenic differentiation and antagonizes the bone morphogenetic protein-2-induced osteoblast conversion by targeting Smad5 for degradation. J Biol Chem\u20082003; 278: 39029\u201336.","DOI":"10.1074\/jbc.M301193200"},{"key":"2022061701332714800_B9","doi-asserted-by":"crossref","unstructured":"Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature\u20082001; 411: 494\u20138.","DOI":"10.1038\/35078107"},{"key":"2022061701332714800_B10","doi-asserted-by":"crossref","unstructured":"Yang YA, Zhang GM, Feigenbaum L, Zhang YE. Smad3 reduces susceptibility to hepatocarcinoma by sensitizing hepatocytes to apoptosis through down-regulation of Bcl-2. Cancer Cell\u20082006; 9: 445\u201357.","DOI":"10.1016\/j.ccr.2006.04.025"},{"key":"2022061701332714800_B11","doi-asserted-by":"crossref","unstructured":"Tang B, Vu M, Booker T, et al. TGF-\u03b2 switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. J Clin Invest\u20082003; 112: 1116\u201324.","DOI":"10.1172\/JCI200318899"},{"key":"2022061701332714800_B12","doi-asserted-by":"crossref","unstructured":"Zhang H, Cohen SN. Smurf2 up-regulation activates telomere-dependent senescence. Genes Dev\u20082004; 18: 3028\u201340.","DOI":"10.1101\/gad.1253004"},{"key":"2022061701332714800_B13","doi-asserted-by":"crossref","unstructured":"Liscovitch M, Ravid D. A case study in misidentification of cancer cell lines: MCF-7\/Adr cells (re-designated NCI\/ADR-RES) are derived from OVCAR-8 human ovarian carcinoma cells. Cancer Lett\u20082007; 245: 350\u20132.","DOI":"10.1016\/j.canlet.2006.01.013"},{"key":"2022061701332714800_B14","doi-asserted-by":"crossref","unstructured":"Brown KA, Aakre ME, Gorska AE, et al. Induction by transforming growth factor-\u03b21 of epithelial to mesenchymal transition is a rare event in vitro. Breast Cancer Res\u20082004; 6: R215\u201331.","DOI":"10.1186\/bcr778"},{"key":"2022061701332714800_B15","doi-asserted-by":"crossref","unstructured":"Sahai R, Garcia-Medina R, Pouyssegur J, Vial E. Smurf1 regulates tumor cell plasticity and motility through degradation of RhoA leading to localized inhibition of contractility. J Cell Biol\u20082007; 176: 35\u201342.","DOI":"10.1083\/jcb.200605135"},{"key":"2022061701332714800_B16","doi-asserted-by":"crossref","unstructured":"Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer\u20082002; 2: 442\u201354.","DOI":"10.1038\/nrc822"},{"key":"2022061701332714800_B17","doi-asserted-by":"crossref","unstructured":"Oft M, Peli J, Rudaz C, et al. TGF-\u03b21 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev\u20081996; 10: 2462\u201377.","DOI":"10.1101\/gad.10.19.2462"},{"key":"2022061701332714800_B18","doi-asserted-by":"crossref","unstructured":"Nieman MT, Prudoff RA, Johnson KR, et al. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol\u20081999; 147: 631\u201344.","DOI":"10.1083\/jcb.147.3.631"},{"key":"2022061701332714800_B19","doi-asserted-by":"crossref","unstructured":"Lin X, Liang M, Feng XH. Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-\u03b2 signaling. J Biol Chem\u20082000; 275: 36818\u201322.","DOI":"10.1074\/jbc.C000580200"},{"key":"2022061701332714800_B20","doi-asserted-by":"crossref","unstructured":"Kavsak P, Rasmussen RK, Causing CG, et al. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF \u03b2 receptor for degradation. Mol Cell\u20082000; 6: 1365\u201375.","DOI":"10.1016\/S1097-2765(00)00134-9"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/3\/735\/2620491\/735.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/3\/735\/2620491\/735.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T03:05:40Z","timestamp":1655435140000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/69\/3\/735\/552720\/Smad-Ubiquitination-Regulatory-Factor-2-Promotes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,29]]},"references-count":20,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2009,1,29]]},"published-print":{"date-parts":[[2009,2,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-08-1463","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22381445","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22381445.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6499871","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6499871.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,29]]}}}